• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.54% Nasdaq Down 1.52%

    Intercept Pharmaceuticals, Inc. (ICPT)

    -NasdaqGS
    274.94 Up 0.50(0.18%) Apr 17, 4:00PM EDT
    |After Hours : 276.50 Up 1.56 (0.57%) Apr 17, 7:59PM EDT
    Add to Portfolio
    Prev Close:274.44
    Open:281.00
    Bid:275.00 x 300
    Ask:280.00 x 100
    1y Target Est:410.33
    Beta:-9.08
    Earnings Date:May 5 - May 11 (Est.)
    Day's Range:270.00 - 283.30
    52wk Range:128.50 - 349.08
    Volume:1,188,352
    Avg Vol (3m):637,384
    Market Cap:6.22B
    P/E (ttm):N/A
    EPS (ttm):-13.63
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Comparison

    Symbol% ChgMkt Cap
    ICPTUp 0.18%6.22B
    AZNDown 0.99%90.09B
    SLXP 0.00%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):3,566.77
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-8.30
    Quarterly EPS Est (Mar-15) :-1.67
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):-1.84

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Intercept Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics to treat chronic liver and intestinal diseases utilizing its proprietary bile acid c... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback